BENEFITS OF RIVAROXABAN AFTER LOWER EXTREMITY REVASCULARIZATION FOR SYMPTOMATIC PERIPHERAL ARTERY DISEASE ARE CONSISTENT WITH AND WITHOUT BACKGROUND STATIN THERAPY

被引:0
|
作者
Heilman, Alexander
Bauersachs, Rupert
Anand, Sonia
Patel, Manesh R.
Debus, Eike S.
Nehler, Mark
Hess, Connie Ng
Capell, Warren H.
Osiemo, Benjamin
Hsia, Judith A.
Muehlhofer, Eva
Haskell, Lloyd
Berkowitz, Scott D.
Bonaca, Marc P.
机构
[1] Colorado Prevent Ctr CPC Clin Res, Aurora, CO USA
[2] Univ Colorado, Anschutz Med Campus, Aurora, CO USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1747 / 1747
页数:1
相关论文
共 50 条
  • [31] Optimal Strategy for Antiplatelet Therapy After Endovascular Revascularization in Patients With Lower Extremity Artery Disease
    Kim, Gwangsil
    Byun, Young Sup
    Kim, Byung Ok
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B87 - B88
  • [32] Anticoagulation in Patients with Premature Peripheral Artery Disease Undergoing Lower Extremity Revascularization
    Kim, Tanner I.
    DeWan, Andrew
    Murray, Michael
    Wang, He
    Mani, Arya
    Mena-Hurtado, Carlos
    Guzman, Raul J.
    Chaar, Cassius Iyad Ochoa
    ANNALS OF VASCULAR SURGERY, 2024, 105 : 150 - 157
  • [33] Comparison of rivaroxaban-based dual antithrombotic and antiplatelet therapies for symptomatic patients with lower-extremity peripheral artery disease post-revascularization: a retrospective cohort study
    Ji, Ye
    Wang, Baoyan
    Wu, Guangyan
    Zhang, Yepeng
    Wang, Qing
    Zhou, Min
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2023, 14
  • [34] Gait changes after supervised exercise training in patients with symptomatic lower extremity peripheral artery disease
    Lanzi, Stefano
    Boichat, Joel
    Calanca, Luca
    Aubertin, Pauline
    Malatesta, Davide
    Mazzolai, Lucia
    VASCULAR MEDICINE, 2021, 26 (03) : 259 - 266
  • [35] Total Adiponectin and Risk of Symptomatic Lower Extremity Peripheral Artery Disease in Men
    Joosten, Michel M.
    Joshipura, Kaumudi J.
    Pai, Jennifer K.
    Bertoia, Monica L.
    Rimm, Eric B.
    Mittleman, Murray A.
    Mukamal, Kenneth J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (05) : 1092 - 1097
  • [36] RIVAROXABAN REDUCES HOSPITALIZATIONS FOR THROMBOEMBOLIC EVENTS IN PATIENTS WITH PERIPHERAL ARTERY DISEASE AFTER REVASCULARIZATION IN THOSE WITH AND WITHOUT CHRONIC KIDNEY DISEASE
    Svet, Mark
    Hsia, Judith A.
    Patel, Manesh R.
    Anand, Sonia
    Debus, E. Sebastian
    Nehler, Mark
    Hess, Connie Ng
    Capell, Warren
    Muehlhofer, Eva
    Haskell, Lloyd
    Berkowitz, Scott D.
    Bauersachs, Rupert
    Bonaca, Marc P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1739 - 1739
  • [37] Ankle-Brachial Index for Risk Stratification in Patients With Symptomatic Peripheral Artery Disease With and Without Prior Lower Extremity Revascularization Observations From the EUCLID Trial
    Hiatt, William R.
    Hess, Connie N.
    Bonaca, Marc P.
    Kavanagh, Sarah
    Patel, Manesh R.
    Baumgartner, Iris
    Berger, Jeffrey S.
    Blomster, Juuso, I
    Jones, W. Schuyler
    Katona, Brian G.
    Mahaffey, Kenneth W.
    Norgren, Lars
    Rockhold, Frank W.
    Fowkes, F. Gerry R.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (07) : E009871
  • [38] Adherence to statin therapy drives survival of patients with symptomatic peripheral artery disease
    Dopheide, J. F.
    Ramadani, H.
    Veit, J.
    Adam, L.
    Papac, L.
    Schindewolf, M.
    Vonbank, A.
    Baumgartner, I.
    Drexel, H.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3256 - 3256
  • [39] Antiplatelet and anticoagulation therapy after revascularization for lower extremity artery disease: a national survey and literature overview
    Ipema, Jetty
    Brand, Aarent R.
    de Borst, Gert J.
    de Vries, Jean-Paul
    Unlu, Cagdas
    JOURNAL OF CARDIOVASCULAR SURGERY, 2021, 62 (01): : 59 - 70
  • [40] Adherence to statin therapy favours survival of patients with symptomatic peripheral artery disease
    Dopheide, Jorn F.
    Veit, Jonas
    Ramadani, Hana
    Adam, Luise
    Papac, Lucija
    Vonbank, Alexander
    Kaspar, Mathias
    Rastan, Aljoscha
    Baumgartner, Iris
    Drexel, Heinz
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (04) : 263 - 270